Items per page
1 - 141 of 141
Title Published in Access level OA Policy Year Views Downloads
Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic ModelingClinical pharmacokinetics
accessLevelPublic
2025 29 24
Impact de la réorganisation des soins pendant les vagues de COVID-19 sur les patients hospitalisés pour un autre diagnostic que le COVID : étude de cohorte rétrospective monocentrique90e Congrès Français de Médecine Interne
accessLevelRestricted
2025 19 0
Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxabanBritish journal of clinical pharmacology
accessLevelRestricted
2025 26 0
Systemic cytokines related to memory function 6-9 months and 12-15 months after SARS-CoV-2 infectionScientific reports
accessLevelPublic
2024 25 69
Monitoring low-value care in medical patients from Swiss university hospitals using a Findable, Accessible, Interoperable, Reusable (FAIR) national data stream and patient and public involvement : LUCID study protocolBMJ open
accessLevelPublic
2024 31 22
Persistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection : A follow-up assessment of the Geneva COVID-COG cohortJournal of global health
accessLevelPublic
2024 75 32
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)BMJ open
accessLevelPublic
2024 71 75
Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG CohortArchives of clinical neuropsychology
accessLevelPublic
2023 437 228
Brain functional connectivity alterations associated with neuropsychological performance 6–9 months following SARS‐CoV ‐2 infectionHuman brain mapping
accessLevelPublic
2023 229 50
Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infectionPsychoneuroendocrinology
accessLevelPublic
2023 177 67
Use of complementary medicine and its association with SARS-CoV-2 vaccination during the COVID-19 pandemic : a longitudinal cohort studySwiss medical weekly
accessLevelPublic
2023 18 15
Markers of limbic system damage following SARS-CoV-2 infectionBrain communications
accessLevelPublic
2023 231 57
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed sideCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2023 131 124
The longitudinal study of subjective wellbeing and absenteeism of healthcare workers considering post-COVID condition and the COVID-19 pandemic tollScientific reports
accessLevelPublic
2023 122 24
Trends in management and outcomes of COVID patients admitted to a Swiss tertiary care hospitalScientific reports
accessLevelPublic
2023 180 39
Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patientsNEJM evidence
accessLevelRestricted
2023 81 0
Prevalence of Post-COVID Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination StatusClinical infectious diseases
accessLevelPublic
2023 145 122
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT studyCPT: pharmacometrics & systems pharmacology
accessLevelPublic
2023 104 87
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendationsBMJ
accessLevelRestricted
2022 10 0
Accuracy of a score predicting the presence of an atypical pathogen in hospitalized patients with moderately severe community-acquired pneumoniaBMC infectious diseases
accessLevelPublic
2022 66 70
A bilateral aseptic pyogenic ventriculitis following a course of pembrolizumab, an anti-PD-1 immune checkpoint inhibitor treatment for metastatic small cell lung cancerThérapie
accessLevelRestricted
2022 31 0
One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individualsJournal of internal medicine
accessLevelPublic
2022 242 73
Comparison of prognostic scores for inpatients with COVID-19: a retrospective monocentric cohort studyBMJ open respiratory research
accessLevelPublic
2022 263 67
Avancées récentes en médecine interneRevue médicale suisse
accessLevelPublic
2022 179 66
Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trialClinical and translational science
accessLevelPublic
2022 132 71
Eight versus 28-point lung ultrasonography in moderate acute heart failure: a prospective comparative studyInternal and emergency medicine
accessLevelPublic
2022 239 126
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World SettingJournal of personalized medicine
accessLevelPublic
2022 200 180
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trialResearch and practice in thrombosis and haemostasis
accessLevelPublic
2022 226 222
Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysisAtherosclerosis
accessLevelPublic
2022 132 335
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure SimulationClinical pharmacology and therapeutics
accessLevelPublic
2022 140 130
Development and assessment of PharmaCheck: an electronic screening tool for the prevention of twenty major adverse drug eventsBMC medical informatics and decision making
accessLevelPublic
2022 243 151
Confidence and use of physical examination and point-of-care ultrasonography for detection of abdominal or pleural free fluid. A cross-sectional surveyInternal and emergency medicine
accessLevelPublic
2022 201 106
The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University HospitalPreventive medicine reports
accessLevelPublic
2022 221 74
Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort studyPloS one
accessLevelPublic
2022 443 187
Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein ActivitiesClinical pharmacology & therapeutics
accessLevelPublic
2022 157 307
Kinetics of inflammatory biomarkers to predict one-year mortality in older patients hospitalized for pneumonia: a multivariable analysisInternational journal of infectious diseases
accessLevelPublic
2022 188 145
The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilizationScientific reports
accessLevelPublic
2022 183 49
Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva CocktailClinical pharmacology and therapeutics
accessLevelPublic
2021 184 106
Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart FailureJournal of clinical medicine
accessLevelPublic
2021 211 67
miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIaThrombosis and haemostasis
accessLevelPublic
2021 84 51
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug TherapyAnnual Review of Pharmacology and Toxicology
accessLevelRestricted
2021 407 1
Drug-drug interactions with direct oral anticoagulants: practical recommendations for cliniciansThe American journal of medicine
accessLevelRestricted
2021 148 0
Mixing Drugs and Genetics: A Complex Hemorrhagic CocktailAmerican Journal of Medicine
accessLevelRestricted
2021 264 5
2020 en revue par les internistes hospitaliersRevue médicale suisse
accessLevelPublic
2021 222 156
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19European journal of hospital pharmacy
accessLevelRestricted
2021 200 0
An Ex Vivo and In Silico Study Providing Insights into the Interplay of Circulating miRNAs Level, Platelet Reactivity and Thrombin Generation: Looking beyond Traditional PharmacogeneticsJournal of Personalized Medicine
accessLevelPublic
2021 224 152
Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with PneumoniaJournal of clinical medicine
accessLevelPublic
2021 244 125
Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settingsJournal of Clinical Medicine
accessLevelPublic
2021 317 145
Role of Intermediate Care Unit Admission and Noninvasive Respiratory Support during the COVID-19 Pandemic: A Retrospective Cohort StudyRespiration
accessLevelPublic
2021 208 191
Accuracy of C-reactive protein, procalcitonin, serum amyloid A and neopterin for low-dose CT-scan confirmed pneumonia in elderly patients: A prospective cohort studyPLOS ONE
accessLevelPublic
2020 339 174
Platelet function test use for patients with coronary artery disease in the early 2020sJournal of clinical medicine
accessLevelPublic
2020 172 87
Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costsSwiss Medical Weekly
accessLevelPublic
2020 475 335
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics ConsortiumClinical Pharmacology and Therapeutics
accessLevelPublic
2020 170 74
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid testEuropean Journal of Clinical Investigation
accessLevelPublic
2020 425 349
MicroRNA-126 is a regulator of platelet-supported thrombin generationPlatelets
accessLevelPublic
2020 287 243
The well-being of Swiss general internal medicine residentsSwiss Medical Weekly
accessLevelPublic
2020 343 222
Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid testsJournal of Clinical Medicine
accessLevelPublic
2020 360 173
Point of care ultrasonography from the emergency department to the internal medicine ward: current trends and perspectivesInternal and Emergency Medicine
accessLevelPublic
2020 284 1,563
Guillain-Barré syndrome as a complication of SARS-CoV-2 infectionBrain, behavior, and immunity
accessLevelPublic
2020 234 71
Functional Independence Measure score is associated with mortality in critically ill elderly patients admitted to an intermediate care unitBMC Geriatrics
accessLevelPublic
2020 204 150
Feasibility and safety of high-intensity interval training for the rehabilitation of geriatric inpatients (HIITERGY) a pilot randomized studyBMC Geriatrics
accessLevelPublic
2020 262 152
Vegetarian, pescatarian and flexitarian diets: sociodemographic determinants and association with cardiovascular risk factors in a Swiss urban populationThe British journal of nutrition
accessLevelPublic
2020 195 132
Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patientsJournal of Thrombosis and Haemostasis
accessLevelRestricted
2020 271 1
Methods to investigate miRNA function: focus on platelet reactivityThrombosis and Haemostasis
accessLevelPublic
2020 227 72
A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot studyJournal of Proteomics
accessLevelPublic
2019 508 368
Functional validation of microRNA-126-3p as a platelet reactivity regulator using human haematopoietic stem cellsThrombosis and Haemostasis
accessLevelPublic
2019 493 418
Associations between early handoffs, length of stay and complications in internal medicine wards: A retrospective studyEuropean journal of internal medicine
accessLevelRestricted
2019 147 1
Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulantsClinical Pharmacokinetics
accessLevelRestricted
2019 472 2
Médecine interne hospitalière en revueRevue médicale suisse
accessLevelPublic
2019 247 128
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysisPLOS ONE
accessLevelPublic
2019 257 161
Platelet Function Testing or Genotyping: Which Should We Trust?JACC: Cardiovascular Interventions
accessLevelRestricted
2019 199 0
Accuracy of comprehensive PCR analysis of nasopharyngeal and oropharyngeal swabs for CT-scan-confirmed pneumonia in elderly patients: a prospective cohort studyClinical Microbiology and Infection
accessLevelPublic
2019 420 143
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active MetabolitesClinical Pharmacokinetics
accessLevelPublic
2018 682 694
Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical PerspectivesClinical Pharmacokinetics
accessLevelPublic
2018 498 673
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)American Heart Journal
accessLevelPublic
2018 470 159
Large bowel obstruction: a case of uncommon aetiology of a frequent conditionAge and Ageing
accessLevelRestricted
2018 252 0
Low-dose computed tomography for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort studyEuropean Respiratory Journal
accessLevelPublic
2018 522 104
Platelet reactivity in stable cardiovascular patients with chronic kidney diseasePlatelets
accessLevelRestricted
2018 506 0
Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective StudyJournal of Bone and Mineral Research
accessLevelRestricted
2018 513 3
Shotgun proteomics data on the impact of hyperglycaemia on platelet protein acetylation by aspirinData in Brief
accessLevelPublic
2018 472 168
Diagnosis of systemic lupus erythematosus by presence of Hargraves cells in eosinophilic pleural effusionMedicine (Baltimore)
accessLevelPublic
2018 230 95
Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular PatientsCell communication & adhesion
accessLevelRestricted
2017 551 2
Acute Appendicitis in Elderly Adults: A Difficult DiagnosisJournal of the American Geriatrics Society
accessLevelRestricted
2016 639 0
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient dataThrombosis and haemostasis
accessLevelPublic
2016 548 177
Genetics of clopidogrel poor-responseAntiplatelet Therapy in Cardiovascular Disease
accessLevelRestricted
2016 497 0
New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approachHuman genetics
accessLevelPublic
2016 808 214
Sepsis chez le sujet âgé : quelles spécificités ?Revue médicale suisse
accessLevelPublic
2016 683 506
PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated PatientsStroke
accessLevelRestricted
2016 534 0
Aspirin response: Differences in serum thromboxane B2 levels between clinical studiesPlatelets
accessLevelRestricted
2016 692 1
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approachClinical pharmacology and therapeutics
accessLevelPublic
2016 635 694
Pharmacogenomics of Oral Antithrombotic DrugsCurrent pharmaceutical design
2016 599 0
Simple comme un SMS !La Revue de médecine interne
accessLevelRestricted
2016 498 146
TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic StrokeStroke
accessLevelRestricted
2016 509 0
An unusual cause of bilateral lower extremity edema in an older womanJournal of the American Geriatrics Society
accessLevelRestricted
2015 553 2
Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies?Expert opinion on pharmacotherapy
accessLevelRestricted
2015 655 2
Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapyArthritis & rheumatology
accessLevelRestricted
2015 578 0
Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo studyPlatelets
accessLevelRestricted
2015 566 0
Mon patient est trop âgé pour une statine : mythes et réalitésRevue médicale suisse
accessLevelRestricted
2015 452 0
Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysisEuropean journal of vascular and endovascular surgery
accessLevelPublic
2015 564 233
Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing?Platelets
accessLevelRestricted
2015 662 3
A Case of Tuberculous Granulomatous Panniculitis without VasculitisCase reports in dermatology
accessLevelPublic
2015 616 261
Pneumonie chez le sujet âgé : y a-t-il des spécificités ?Revue médicale suisse
accessLevelRestricted
2014 588 2
Hémostase. Aspirine: une ou deux fois par jour?Revue médicale suisse
accessLevelRestricted
2014 560 0
How to manage prasugrel and ticagrelor in daily practiceEuropean journal of internal medicine
accessLevelPublic
2014 477 488
Antiplatelet Therapy: Targeting the TxA2 PathwayJournal of cardiovascular translational research
accessLevelRestricted
2014 625 2
Role of paraoxonase-1 in CYP2C19 loss-of-function carriersThrombosis research
accessLevelRestricted
2014 653 0
Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granulesJournal of proteomics
accessLevelRestricted
2014 776 3
Tailored Thienopyridine therapy: no urgency for CYP2C19 genotypingJournal of the American Heart Association. Cardiovascular and cerebrovascular disease
accessLevelRestricted
2013 570 0
Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ?Revue médicale suisse
accessLevelRestricted
2013 554 0
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleedingJournal of the American College of Cardiology
accessLevelPublic
2013 488 777
Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigmTranslational proteomics
accessLevelPublic
2013 629 537
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events studyCirculation
accessLevelPublic
2012 717 29
Intramural hematoma of the esophagusCase reports in gastroenterology
accessLevelRestricted
2012 525 0
Application pratique et intérêt des recommandations de prise en charge des syncopes : évaluation de pratiques professionnellesAnnales de cardiologie et d'angéiologie
accessLevelRestricted
2012 548 0
Prevalence of poor biological response to clopidogrel: a systematic reviewThrombosis and haemostasis
accessLevelRestricted
2012 522 0
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and managementCardiovascular therapeutics
accessLevelRestricted
2012 612 0
Nutrition entérale : sonde nasogastrique ou gastrostomie percutanée endoscopique?Revue médicale suisse
accessLevelRestricted
2012 617 2
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysisJournal of thrombosis and haemostasis
accessLevelRestricted
2012 601 0
Severe mitral valve regurgitation in polymyositisJournal of clinical rheumatology
accessLevelRestricted
2012 543 0
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitroBritish journal of pharmacology
accessLevelRestricted
2012 554 0
Thrombose coronaire distale compliquant une leucémie aiguë lymphoblastique traitée par asparaginaseAnnales de cardiologie et d'angéiologie
accessLevelPublic
2012 664 515
Platelet proteomicsMass spectrometry reviews
accessLevelRestricted
2012 522 2
Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE studyJournal of thrombosis and haemostasis
accessLevelRestricted
2011 620 0
Une histoire pas très originale dans un contexte pas très confortable...Hemoptysis in a 55-year-old manLa Revue de médecine interne
accessLevelRestricted
2011 615 0
Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patientsThrombosis and haemostasis
accessLevelRestricted
2011 631 0
Anémie ferriprive, inflammatoire ou mixte: comment orienter le diagnostic?Revue médicale suisse
accessLevelRestricted
2011 1,261 5
Médecine interne hospitalière : l'année 2010 en revue (1)Revue médicale suisse
accessLevelRestricted
2011 956 0
Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysisJournal of thrombosis and haemostasis
accessLevelRestricted
2010 545 0
Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragiqueRevue médicale suisse
2010 593 0
Médecine interne hospitalière : l'année 2009 en revue (2)Revue médicale suisse
accessLevelRestricted
2010 571 1
Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype?Revue médicale suisse
2010 505 0
Antiagregants plaquettaires : lequel, quand et pour qui ?La Revue de médecine interne
accessLevelRestricted
2010 494 0
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE studyJournal of thrombosis and haemostasis
accessLevelRestricted
2010 578 0
Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistanceCurrent vascular pharmacology
2009 505 0
Le concept de "resistance" a l'aspirine: mecanismes et pertinence cliniqueLa Revue de médecine interne
accessLevelRestricted
2009 541 0
Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided?Journal of thrombosis and haemostasis
accessLevelRestricted
2009 502 0
Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysisJournal of thrombosis and haemostasis
accessLevelRestricted
2008 640 0
Laboratory-defined aspirin resistance and recurrent cardiovascular eventsArchives of internal medicine
accessLevelRestricted
2008 559 0
Aspirin "resistance" and risk of cardiovascular morbidityBMJ. British medical journal
accessLevelRestricted
2008 515 1
Aspirin response variability assessed with the PFA-100 deviceThrombosis and haemostasis
2008 590 0
Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjectsCirculation
accessLevelPublic
2003 268 98
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack